Allegra and Hyperuricaemia - a phase IV clinical study of FDA data

Summary:

Hyperuricaemia is reported as a side effect among people who take Allegra (fexofenadine hydrochloride), especially for people who are male, 60+ old, have been taking the drug for < 1 month also take Rebetol, and have Hepatitis c.

The phase IV clinical study analyzes which people have Hyperuricaemia when taking Allegra. It is created by eHealthMe based on reports of 73,095 people who have side effects when taking Allegra from the FDA, and is updated regularly.

What is Allegra?

Allegra has active ingredients of fexofenadine hydrochloride. It is often used in allergies. eHealthMe is studying from 75,497 Allegra users. Check the latest studies of Allegra.

What is Hyperuricaemia?

Hyperuricaemia (level of uric acid in the blood that is abnormally high) is found to be associated with 700 drugs and 791 conditions by eHealthMe. Check the latest studies of Hyperuricaemia.

On Jul, 26, 2026

73,095 people reported to have side effects when taking Allegra.
Among them, 72 people (0.1%) have Hyperuricaemia.

Among these 72 people:

How long have people been on Allegra when they have Hyperuricaemia? *

What is the gender of people who have Hyperuricaemia when taking Allegra? *

female: 38.46 %
male: 61.54 %

What is the age of people who have Hyperuricaemia when taking Allegra? *

What are other drugs people take besides Allegra? *

What are other side effects people have besides Hyperuricaemia? *

Anaemia (lack of blood): 18 people, 25.00%
Renal Disorder (kidney disease): 14 people, 19.44%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 13 people, 18.06%
Rashes (redness): 13 people, 18.06%
Thrombocytopenia (decrease of platelets in blood): 12 people, 16.67%
Haemoglobin Decreased: 12 people, 16.67%
Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters): 10 people, 13.89%
Nausea (feeling of having an urge to vomit): 10 people, 13.89%
Insomnia (sleeplessness): 8 people, 11.11%
Oedema Peripheral (superficial swelling): 7 people, 9.72%

What are the existing conditions these people have? *

Hepatitis C: 13 people, 18.06%
High Blood Pressure: 12 people, 16.67%
Lupus Nephritis (a chronic inflammatory autoimmune disorder that may affect kidney tissue): 11 people, 15.28%
Rashes (redness): 8 people, 11.11%
Hyperlipidaemia (presence of excess lipids in the blood): 6 people, 8.33%
Constipation: 6 people, 8.33%
Insomnia (sleeplessness): 5 people, 6.94%
Nausea (feeling of having an urge to vomit): 5 people, 6.94%
Depression: 5 people, 6.94%
Heavy Or Prolong Menstrual Bleeding: 5 people, 6.94%

* Approximation only. Some reports may have incomplete information.

Do you take Allegra and have Hyperuricaemia?

- Check whether Hyperuricaemia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Allegra:

Allegra (75,497 reports)

Hyperuricaemia treatments and more:

Hyperuricaemia (25,670 reports)

Browse all side effects of Allegra:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Hyperuricaemia:

Hyperuricaemia (700 drugs)

Browse all the conditions that are associated with Hyperuricaemia:

Hyperuricaemia (791 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on fexofenadine hydrochloride (the active ingredients of Allegra) and Allegra (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.